Centre de Recherche sur Volontaire
Bobigny, 93000, France
Location status: Recruiting
Location contact
Mourad BENALLAOUA, PhD
CONTACT
Robert BENAMOUZIG, Pr
CONTACT
NCT Number: NCT05758961
" The French Gut " is a national contribution aiming to collect 100,000 faecal samples and associated nutritional and clinical data by 2027. Le French Gut is initiated by MetaGenoPolis-INRAE, supported by INRAE with Prof. R. Benamouzig, (AP-HP) as principal investigator of the project. The main goal of this national trial is a better understanding of the observed heterogeneity between gut microbiome of healthy subjects, its connections with the diet and lifestyle, but also changes in gut microbiota associated with diseases (diabetes, obesity, allergies, cancer, Parkinson, Alzheimer…).
Interested in participating?
Request Info18 year and older
All sexes
Observational
Bobigny, 93000, France
Location status: Recruiting
Mourad BENALLAOUA, PhD
CONTACT
Robert BENAMOUZIG, Pr
CONTACT
At the 14th International Conference on Genomics (ICG-14), scientists from China, Sweden, Denmark, France and Latvia launched The Million Microbiome of Humans Project (MMHP) and agreed to collaborate on a large-scale microbial metagenomic project. The overarching goal is to build the world's largest database of human microbiota with one million microbial samples from the intestines, mouth, skin and reproductive system. Therefore, making it possible to characterize the microbiota of people according to age, gender, height, weight, etc.
As a founding member of the MMHP, INRAE will bring the French national contribution: 100 000 faecal samples and associated nutritional and clinical data from France, by 2027, through Le French Gut project. Initiated by the MGP research unit, Le French Gut is led by INRAE and the AP-HP (Public Assistance-Hospitals of Paris), with the support and collaboration of a consortium of members from medical, scientific and industrial sectors.
In order to be a participant of the project, volunteers will need to fill out an online questionnaire with 60 questions about their lifestyle, their dietary habits and their medical background. The second requirement is the stool sampling, at home.
Main scientific targets of this project are the following:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non inclusion Criteria:
Time frame: 5 up to 15 years
The gut microbiota of participants will be characterized by describing the presence and abundance in the samples of each gut microbial genes listed in our up-to-date gene catalogue. From these data, the presence and abundance of the different taxonomic ranks will be deduced, ranging from a fine granularity at species and strain level to a more 'zoomed out' phylum level. The richness and diversity of the microbiome (genes and species) will be described. The functional modules, corresponding to the metabolic pathways encoded by the species detected in each sample, will be determined.
Time frame: 5 up to 15 years
Time frame: 5 up to 15 years
Time frame: 5 up to 15 years
Richness and diversity of the microbiota (genes and species);
Time frame: 5 up to 15 years
Time frame: 5 up to 15 years
Contact information is provided by the study sponsor or research team.
Mourad BENALLAOUA, PhD
CONTACT
Robert BENAMOUZIG, Pr
CONTACT
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Other
Le French Gut : the French Microbiota
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05400824
Arbovirus Infections, Cardiovascular Diseases
La Réunion, Saint-Pierre, France
View Trial DetailsNCT06166810
General Population
Clermont-Ferrand, France
View Trial DetailsNCT05328856
General Population
Berlin, State of Berlin, Germany
View Trial DetailsNCT06017687
General Population
Truckee, California, United States
View Trial Details